Eli Lilly headquarters located in Indianapolis, Indiana.

The U.S. Food and Drug Administration found eight separate manufacturing problems at an Eli Lilly plant in Branchburg, N.J., during an inspection last summer. The inspection report, obtained by Reuters under a Freedom of Information Act request, cited problems in tracking manufacturing processes and quality controls; lapses in equipment calibration; and failure to properly maintain facilities and equipment.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee Participation
Employee-Paid
Employer-Paid